Table 1.
Baseline characteristics of the study population.
| All (N=1157) | Men (N=395) | Women (N=762) | Sig. | |
|---|---|---|---|---|
| Age (years) | 20.3 ± 1.8 | 20.4 ± 1.8 | 20.2 ± 1.7 | 0.195 |
| BMI (kg/m2) | 29.1 ± 6.3 | 28.3 ± 5.9 | 29.6 ± 6.6 | 0.002* |
| Height (cm) | 163.8 ± 8.0 | 171.9 ± 5.7 | 159.6 ± 5.4 | <0.001* |
| Weight (kg) | 78.4 ± 19.0 | 84.1 ± 19.1 | 75.5 ± 18.2 | <0.001* |
| Fasting glucose (mg/dL) (N=803) | 90.0 ± 8.1 | 92.2 ± 9.0 | 88.8 ± 7.3 | <0.001* |
| 2-h glucose (mg/dL) (N=1140) | 100.7 ± 22.6 | 96.4 ± 22.3 | 103.0 ± 22.4 | <0.001* |
| Fasting insulin (mU/L) (N=791) | 23.9 ± 18.3 | 21.1 ± 14.6 | 25.4 ± 19.9 | 0.002* |
| Median and IQR | 19 (12-31) | 18 (11-28) | 20 (12-34) | 0.006*# |
| Logarithmic values | 1.5 ± 0.3 | 1.4 ± 0.3 | 1.5 ± 0.3 | 0.159 |
| 2-h insulin (mU/L) (N=811) | 108.3 ± 106.7 | 78.9 ± 88.0 | 123.9 ± 112.4 | <0.001* |
| Median and IQR | 84 (42-135) | 50 (27-100) | 95 (53-150) | <0.001*# |
| Logarithmic values | 2.0 ± 0.4 | 1.9 ± 0.4 | 2.1 ± 0.3 | <0.001* |
| Total cholesterol (mg/dL) (N=1134) | 160.9 ± 31.0 | 164.9 ± 32.8 | 158.8 ± 29.8 | 0.002* |
| Systolic BP (mmHg) (N=1117) | 115.5 ± 13.6 | 123.8 ± 13.2 | 111.2 ± 11.7 | <0.001* |
| Diastolic BP (mmHg) (N=1115) | 66.4 ± 10.5 | 69.8 ± 10.9 | 64.7 ± 9.8 | <0.001* |
*
P <0.05 for gender
#
Mann-Whitney U test P -value.